. 2019 Feb 1;12:209–215. doi: 10.2147/DMSO.S184437

Table 4.

Common adverse effects at 26 weeks

Common adverse effects and their incidence at 26 weeks from five studies
Side effect	Incidence in %

	Placebo	Canagliflozin 100 mg	Canagliflozin 300 mg

Volume depletion	0.68	0.87	1.63
Osmotic diuresis	0.95	5.09^a	5.09^a

Genital mycotic infection

Overall	1.63	6.17^a	6.5^a
Male	0.51	3.65^a	2.88^a
Female	2.9	8.75^a	9.98^a

Note:

P<0.05. Data from Xiong et al.²¹